{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:30:07Z","timestamp":1763469007442,"version":"3.40.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98591-y","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T13:43:42Z","timestamp":1745329422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["To establish and validate autophagy related biomarkers for the diagnosis of IgA nephropathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Sijia","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hangyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"98591_CR1","doi-asserted-by":"publisher","first-page":"105223","DOI":"10.1016\/j.isci.2022.105223","volume":"25","author":"Y Ohyama","year":"2022","unstructured":"Ohyama, Y. et al. Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy. iScience 25, 105223. https:\/\/doi.org\/10.1016\/j.isci.2022.105223 (2022).","journal-title":"iScience"},{"key":"98591_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/j.ajkd.2023.12.016","volume":"84","author":"C Tang","year":"2024","unstructured":"Tang, C. et al. Time-varying proteinuria and progression of IgA nephropathy: A cohort study. Am. J. Kidney Dis. 84, 170-178.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2023.12.016 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"98591_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00281-021-00888-3","volume":"43","author":"J Floege","year":"2021","unstructured":"Floege, J., Rauen, T. & Tang, S. C. W. Current treatment of IgA nephropathy. Semin. Immunopathol. 43, 717\u2013728. https:\/\/doi.org\/10.1007\/s00281-021-00888-3 (2021).","journal-title":"Semin. Immunopathol."},{"key":"98591_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin, B. H. et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int. 100, 753\u2013779. https:\/\/doi.org\/10.1016\/j.kint.2021.05.015 (2021).","journal-title":"Kidney Int."},{"key":"98591_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","volume":"78","author":"P Pattrapornpisut","year":"2021","unstructured":"Pattrapornpisut, P., Avila-Casado, C. & Reich, H. N. IgA nephropathy: Core curriculum 2021. Am. J. Kidney Dis. 78, 429\u2013441. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.024 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"98591_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.autrev.2015.05.009","volume":"14","author":"RN Moresco","year":"2015","unstructured":"Moresco, R. N., Speeckaert, M. M. & Delanghe, J. R. Diagnosis and monitoring of IgA nephropathy: The role of biomarkers as an alternative to renal biopsy. Autoimmun. Rev. 14, 847\u2013853. https:\/\/doi.org\/10.1016\/j.autrev.2015.05.009 (2015).","journal-title":"Autoimmun. Rev."},{"key":"98591_CR7","doi-asserted-by":"publisher","first-page":"1326026","DOI":"10.3389\/fimmu.2024.1326026","volume":"15","author":"ZY Duan","year":"2024","unstructured":"Duan, Z. Y. et al. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy. Front. Immunol. 15, 1326026. https:\/\/doi.org\/10.3389\/fimmu.2024.1326026 (2024).","journal-title":"Front. Immunol."},{"key":"98591_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine, B. & Kroemer, G. Biological functions of autophagy genes: A disease perspective. Cell 176, 11\u201342. https:\/\/doi.org\/10.1016\/j.cell.2018.09.048 (2019).","journal-title":"Cell"},{"key":"98591_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev-physiol-021119-034658","volume":"82","author":"ME Choi","year":"2020","unstructured":"Choi, M. E. Autophagy in kidney disease. Annu. Rev. Physiol. 82, 297\u2013322. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034658 (2020).","journal-title":"Annu. Rev. Physiol."},{"key":"98591_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","volume":"16","author":"C Tang","year":"2020","unstructured":"Tang, C., Livingston, M. J., Liu, Z. & Dong, Z. Autophagy in kidney homeostasis and disease. Nat. Rev. Nephrol. 16, 489\u2013508. https:\/\/doi.org\/10.1038\/s41581-020-0309-2 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"98591_CR11","doi-asserted-by":"publisher","first-page":"901465","DOI":"10.3389\/fimmu.2022.901465","volume":"13","author":"W Du","year":"2022","unstructured":"Du, W. et al. Increased proportion of follicular helper T cells is associated with B cell activation and disease severity in IgA nephropathy. Front. Immunol. 13, 901465. https:\/\/doi.org\/10.3389\/fimmu.2022.901465 (2022).","journal-title":"Front. Immunol."},{"key":"98591_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4049\/jimmunol.1900284","volume":"205","author":"CY Wu","year":"2020","unstructured":"Wu, C. Y. et al. IgA nephropathy benefits from compound K treatment by inhibiting NF-\u03baB\/NLRP3 inflammasome and enhancing autophagy and SIRT1. J. Immunol. 205, 202\u2013212. https:\/\/doi.org\/10.4049\/jimmunol.1900284 (2020).","journal-title":"J. Immunol."},{"key":"98591_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.molmed.2016.06.001","volume":"22","author":"H Zhang","year":"2016","unstructured":"Zhang, H., Puleston, D. J. & Simon, A. K. Autophagy and Immune Senescence. Trends Mol. Med. 22, 671\u2013686. https:\/\/doi.org\/10.1016\/j.molmed.2016.06.001 (2016).","journal-title":"Trends Mol. Med."},{"key":"98591_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.immuni.2021.01.018","volume":"54","author":"V Deretic","year":"2021","unstructured":"Deretic, V. Autophagy in inflammation, infection, and immunometabolism. Immunity 54, 437\u2013453. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.018 (2021).","journal-title":"Immunity"},{"key":"98591_CR15","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1681\/asn.2016101103","volume":"28","author":"P Liu","year":"2017","unstructured":"Liu, P. et al. Transcriptomic and proteomic profiling provides insight into mesangial cell function in IgA nephropathy. J. Am. Soc. Nephrol. 28, 2961\u20132972. https:\/\/doi.org\/10.1681\/asn.2016101103 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"98591_CR16","doi-asserted-by":"publisher","first-page":"e13451","DOI":"10.1371\/journal.pone.0013451","volume":"5","author":"HN Reich","year":"2010","unstructured":"Reich, H. N. et al. A molecular signature of proteinuria in glomerulonephritis. PLoS ONE 5, e13451. https:\/\/doi.org\/10.1371\/journal.pone.0013451 (2010).","journal-title":"PLoS ONE"},{"key":"98591_CR17","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/ndt\/gfv017","volume":"30","author":"SN Cox","year":"2015","unstructured":"Cox, S. N. et al. Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients. Nephrol. Dial. Transplant 30, 1122\u20131232. https:\/\/doi.org\/10.1093\/ndt\/gfv017 (2015).","journal-title":"Nephrol. Dial. Transplant"},{"key":"98591_CR18","doi-asserted-by":"publisher","first-page":"15164","DOI":"10.1038\/s41598-020-72026-2","volume":"10","author":"SN Cox","year":"2020","unstructured":"Cox, S. N. et al. Formalin-fixed paraffin-embedded renal biopsy tissues: An underexploited biospecimen resource for gene expression profiling in IgA nephropathy. Sci. Rep. 10, 15164. https:\/\/doi.org\/10.1038\/s41598-020-72026-2 (2020).","journal-title":"Sci. Rep."},{"key":"98591_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"98591_CR20","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"98591_CR21","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592. https:\/\/doi.org\/10.1093\/nar\/gkac963 (2023).","journal-title":"Nucleic Acids Res."},{"key":"98591_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/bs.pmbts.2020.01.008","volume":"172","author":"D Bhatia","year":"2020","unstructured":"Bhatia, D. & Choi, M. E. Autophagy in kidney disease: Advances and therapeutic potential. Prog. Mol. Biol. Transl. Sci. 172, 107\u2013133. https:\/\/doi.org\/10.1016\/bs.pmbts.2020.01.008 (2020).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"98591_CR23","doi-asserted-by":"publisher","first-page":"154913","DOI":"10.1016\/j.phymed.2023.154913","volume":"117","author":"S Ma","year":"2023","unstructured":"Ma, S. et al. Effects and mechanisms of Chinese herbal medicine on IgA nephropathy. Phytomedicine 117, 154913. https:\/\/doi.org\/10.1016\/j.phymed.2023.154913 (2023).","journal-title":"Phytomedicine"},{"key":"98591_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000456039","volume":"45","author":"D Liu","year":"2017","unstructured":"Liu, D. et al. Rapamycin enhances repressed autophagy and attenuates aggressive progression in a rat model of IgA nephropathy. Am. J. Nephrol. 45, 293\u2013300. https:\/\/doi.org\/10.1159\/000456039 (2017).","journal-title":"Am. J. Nephrol."},{"key":"98591_CR25","doi-asserted-by":"publisher","first-page":"e13278","DOI":"10.1111\/cpr.13278","volume":"55","author":"L Zhao","year":"2022","unstructured":"Zhao, L. et al. Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9\/p38 MAPK pathway. Cell Prolif. 55, e13278. https:\/\/doi.org\/10.1111\/cpr.13278 (2022).","journal-title":"Cell Prolif."},{"key":"98591_CR26","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/15548627.2017.1309485","volume":"13","author":"T Kimura","year":"2017","unstructured":"Kimura, T., Isaka, Y. & Yoshimori, T. Autophagy and kidney inflammation. Autophagy 13, 997\u20131003. https:\/\/doi.org\/10.1080\/15548627.2017.1309485 (2017).","journal-title":"Autophagy"},{"key":"98591_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2017.01.007","volume":"176","author":"DJ Wu","year":"2017","unstructured":"Wu, D. J. & Adamopoulos, I. E. Autophagy and autoimmunity. Clin. Immunol. 176, 55\u201362. https:\/\/doi.org\/10.1016\/j.clim.2017.01.007 (2017).","journal-title":"Clin. Immunol."},{"key":"98591_CR28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s12916-024-03729-w","volume":"22","author":"J Xiao","year":"2024","unstructured":"Xiao, J. et al. TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy. BMC Med. 22, 502. https:\/\/doi.org\/10.1186\/s12916-024-03729-w (2024).","journal-title":"BMC Med."},{"key":"98591_CR29","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1080\/15548627.2024.2315893","volume":"20","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy, H. M. et al. Defective autophagy and autophagy activators in myasthenia gravis: A rare entity and unusual scenario. Autophagy 20, 1473\u20131482. https:\/\/doi.org\/10.1080\/15548627.2024.2315893 (2024).","journal-title":"Autophagy"},{"key":"98591_CR30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.trecan.2021.05.003","volume":"7","author":"E White","year":"2021","unstructured":"White, E., Lattime, E. C. & Guo, J. Y. Autophagy regulates stress responses, metabolism, and anticancer immunity. Trends Cancer 7, 778\u2013789. https:\/\/doi.org\/10.1016\/j.trecan.2021.05.003 (2021).","journal-title":"Trends Cancer"},{"key":"98591_CR31","doi-asserted-by":"publisher","first-page":"e23358","DOI":"10.1002\/jbt.23358","volume":"37","author":"D Chang","year":"2023","unstructured":"Chang, D., Li, L., Xu, Z. & Chen, X. Targeting FOS attenuates malignant phenotypes of breast cancer: Evidence from in silico and in vitro studies. J. Biochem. Mol. Toxicol. 37, e23358. https:\/\/doi.org\/10.1002\/jbt.23358 (2023).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"98591_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s42003-023-04454-5","volume":"6","author":"Q Li","year":"2023","unstructured":"Li, Q. et al. Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos. Commun. Biol. 6, 52. https:\/\/doi.org\/10.1038\/s42003-023-04454-5 (2023).","journal-title":"Commun. Biol."},{"key":"98591_CR33","doi-asserted-by":"publisher","first-page":"840890","DOI":"10.3389\/fphys.2022.840890","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Wang, N., Zhang, Y. & Yu, P. Expression of CCL2, FOS, and JUN may help to distinguish patients with IgA nephropathy from healthy controls. Front. Physiol. 13, 840890. https:\/\/doi.org\/10.3389\/fphys.2022.840890 (2022).","journal-title":"Front. Physiol."},{"key":"98591_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/jcla.21699","volume":"28","author":"HJ Park","year":"2014","unstructured":"Park, H. J., Kim, J. W., Cho, B. S. & Chung, J. H. Association of FOS-like antigen 1 promoter polymorphism with podocyte foot process effacement in immunoglobulin A nephropathy patients. J. Clin. Lab. Anal. 28, 391\u2013397. https:\/\/doi.org\/10.1002\/jcla.21699 (2014).","journal-title":"J. Clin. Lab. Anal."},{"key":"98591_CR35","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.3892\/mmr.2018.9355","volume":"18","author":"J Gao","year":"2018","unstructured":"Gao, J. et al. In vitro and in vivo study of the expression of the Syk\/Ras\/c-Fos pathway in chronic glomerulonephritis. Mol. Med. Rep. 18, 3683\u20133690. https:\/\/doi.org\/10.3892\/mmr.2018.9355 (2018).","journal-title":"Mol. Med. Rep."},{"key":"98591_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12929-020-00660-z","volume":"27","author":"YM Chao","year":"2020","unstructured":"Chao, Y. M. et al. Anomalous AMPK-regulated angiotensin AT(1)R expression and SIRT1-mediated mitochondrial biogenesis at RVLM in hypertension programming of offspring to maternal high fructose exposure. J. Biomed. Sci. 27, 68. https:\/\/doi.org\/10.1186\/s12929-020-00660-z (2020).","journal-title":"J. Biomed. Sci."},{"key":"98591_CR37","doi-asserted-by":"publisher","first-page":"117452","DOI":"10.1016\/j.lfs.2020.117452","volume":"248","author":"A Mirshafa","year":"2020","unstructured":"Mirshafa, A. et al. Tropisetron protects against brain aging via attenuating oxidative stress, apoptosis and inflammation: The role of SIRT1 signaling. Life Sci. 248, 117452. https:\/\/doi.org\/10.1016\/j.lfs.2020.117452 (2020).","journal-title":"Life Sci."},{"key":"98591_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/fjc.0000000000000837","volume":"76","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. Resveratrol attenuates aortic dissection by increasing endothelial barrier function through the SIRT1 pathway. J. Cardiovasc. Pharmacol. 76, 86\u201393. https:\/\/doi.org\/10.1097\/fjc.0000000000000837 (2020).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"98591_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/antiox13030284","volume":"13","author":"A Islam","year":"2024","unstructured":"Islam, A., Chang, Y. C., Tsao, N. W., Wang, S. Y. & Chueh, P. J. Calocedrus formosana essential oils induce ROS-mediated autophagy and apoptosis by targeting SIRT1 in colon cancer cells. Antioxidants (Basel) 13, 284. https:\/\/doi.org\/10.3390\/antiox13030284 (2024).","journal-title":"Antioxidants (Basel)"},{"key":"98591_CR40","doi-asserted-by":"publisher","first-page":"114872","DOI":"10.1016\/j.ecoenv.2023.114872","volume":"256","author":"D Yan","year":"2023","unstructured":"Yan, D. et al. SIRT1\/FOXO3-mediated autophagy signaling involved in manganese-induced neuroinflammation in microglia. Ecotoxicol. Environ. Saf. 256, 114872. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.114872 (2023).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"98591_CR41","doi-asserted-by":"publisher","DOI":"10.1172\/jci149415","author":"JA Kirk","year":"2021","unstructured":"Kirk, J. A., Cheung, J. Y. & Feldman, A. M. Therapeutic targeting of BAG3: Considering its complexity in cancer and heart disease. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci149415 (2021).","journal-title":"J. Clin. Invest."},{"key":"98591_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40001-024-01687-w","volume":"29","author":"B Gong","year":"2024","unstructured":"Gong, B. et al. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates. Eur. J. Med. Res. 29, 93. https:\/\/doi.org\/10.1186\/s40001-024-01687-w (2024).","journal-title":"Eur. J. Med. Res."},{"key":"98591_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1177\/1535370214558023","volume":"240","author":"F Du","year":"2015","unstructured":"Du, F. et al. Implication of Bcl-2-associated athanogene 3 in fibroblast growth factor-2-mediated epithelial-mesenchymal transition in renal epithelial cells. Exp. Biol. Med. (Maywood) 240, 566\u2013575. https:\/\/doi.org\/10.1177\/1535370214558023 (2015).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"98591_CR44","first-page":"6214","volume":"11","author":"O Alhalabi","year":"2021","unstructured":"Alhalabi, O. & Msaouel, P. Truncating CDKN1A mutations: An insight into the biology of urinary tract carcinomas?. Am. J. Cancer Res. 11, 6214\u20136217 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"98591_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020465","author":"R Ohashi","year":"2020","unstructured":"Ohashi, R. et al. Loss of CDKN1A mRNA and protein expression are independent predictors of poor outcome in chromophobe renal cell carcinoma patients. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12020465 (2020).","journal-title":"Cancers (Basel)"},{"key":"98591_CR46","doi-asserted-by":"publisher","first-page":"F1350","DOI":"10.1152\/ajprenal.00254.2019","volume":"317","author":"J Yang","year":"2019","unstructured":"Yang, J. et al. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A. Am. J. Physiol. Renal Physiol. 317, F1350-f1358. https:\/\/doi.org\/10.1152\/ajprenal.00254.2019 (2019).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"98591_CR47","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.26355\/eurrev_202007_22205","volume":"24","author":"JS Dong","year":"2020","unstructured":"Dong, J. S., Wu, B. & Jiang, B. LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of renal cell cancer cells by downregulating CDKN1A. Eur. Rev. Med. Pharmacol. Sci. 24, 7556. https:\/\/doi.org\/10.26355\/eurrev_202007_22205 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"98591_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fimmu.2016.00117","volume":"7","author":"B Knoppova","year":"2016","unstructured":"Knoppova, B. et al. The origin and activities of IgA1-containing immune complexes in IgA nephropathy. Front. Immunol. 7, 117. https:\/\/doi.org\/10.3389\/fimmu.2016.00117 (2016).","journal-title":"Front. Immunol."},{"key":"98591_CR49","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2215\/cjn.07420716","volume":"12","author":"JC Rodrigues","year":"2017","unstructured":"Rodrigues, J. C., Haas, M. & Reich, H. N. IgA nephropathy. Clin. J. Am. Soc. Nephrol. 12, 677\u2013686. https:\/\/doi.org\/10.2215\/cjn.07420716 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"98591_CR50","doi-asserted-by":"publisher","first-page":"11462","DOI":"10.7150\/thno.49778","volume":"10","author":"JW He","year":"2020","unstructured":"He, J. W., Zhou, X. J., Lv, J. C. & Zhang, H. Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies. Theranostics 10, 11462\u201311478. https:\/\/doi.org\/10.7150\/thno.49778 (2020).","journal-title":"Theranostics"},{"key":"98591_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102810","author":"D Maixnerova","year":"2022","unstructured":"Maixnerova, D., El Mehdi, D., Rizk, D. V., Zhang, H. & Tesar, V. New treatment strategies for IgA nephropathy: Targeting plasma cells as the main source of pathogenic antibodies. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm11102810 (2022).","journal-title":"J. Clin. Med."},{"key":"98591_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3892\/etm.2020.8673","volume":"20","author":"Y Tang","year":"2020","unstructured":"Tang, Y., He, H., Hu, P. & Xu, X. T lymphocytes in IgA nephropathy. Exp. Ther. Med. 20, 186\u2013194. https:\/\/doi.org\/10.3892\/etm.2020.8673 (2020).","journal-title":"Exp. Ther. Med."},{"key":"98591_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","volume":"23","author":"A Zhang","year":"2024","unstructured":"Zhang, A. et al. Regulatory T cells in immune checkpoint blockade antitumor therapy. Mol. Cancer 23, 251. https:\/\/doi.org\/10.1186\/s12943-024-02156-y (2024).","journal-title":"Mol. Cancer"},{"key":"98591_CR54","first-page":"284","volume":"19","author":"BL Shen","year":"2015","unstructured":"Shen, B. L. et al. Study on the effects of regulatory T cells on renal function of IgAN rat model. Eur. Rev. Med. Pharmacol. Sci. 19, 284\u2013288 (2015).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"98591_CR55","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1681\/asn.2021060815","volume":"32","author":"D Xie","year":"2021","unstructured":"Xie, D. et al. Intensity of macrophage infiltration in glomeruli predicts response to immunosuppressive therapy in patients with IgA nephropathy. J. Am. Soc. Nephrol. 32, 3187\u20133196. https:\/\/doi.org\/10.1681\/asn.2021060815 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"98591_CR56","doi-asserted-by":"publisher","first-page":"681748","DOI":"10.3389\/fimmu.2021.681748","volume":"12","author":"Y Wen","year":"2021","unstructured":"Wen, Y., Yan, H. R., Wang, B. & Liu, B. C. Macrophage heterogeneity in kidney injury and fibrosis. Front. Immunol. 12, 681748. https:\/\/doi.org\/10.3389\/fimmu.2021.681748 (2021).","journal-title":"Front. Immunol."},{"key":"98591_CR57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cellsig.2013.11.004","volume":"26","author":"D Zhou","year":"2014","unstructured":"Zhou, D. et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal 26, 192\u2013197. https:\/\/doi.org\/10.1016\/j.cellsig.2013.11.004 (2014).","journal-title":"Cell Signal"},{"key":"98591_CR58","doi-asserted-by":"publisher","first-page":"646650","DOI":"10.3389\/fimmu.2021.646650","volume":"12","author":"M Yang","year":"2021","unstructured":"Yang, M., Liu, J. W., Zhang, Y. T. & Wu, G. The role of renal macrophage, AIM, and TGF-\u03b21 expression in renal fibrosis progression in IgAN patients. Front. Immunol. 12, 646650. https:\/\/doi.org\/10.3389\/fimmu.2021.646650 (2021).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98591-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T13:43:43Z","timestamp":1745329423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98591-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98591"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98591-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"These studies involving human were approved by the Ethics Committee of Xiyuan Hospital, China Academy of Chinese Medical Sciences (2022XLA088-1). All methods were carried out in accordance with relevant guidelines and regulations. Participants provided written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"13944"}}